Trials / Unknown
UnknownNCT03857347
Psychoeducation Group Intervention for FND
A Feasibility Study for a Psycho-education Intervention for People With a Functional Neurological Disorder.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- University of Edinburgh · Academic / Other
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to assess the feasibility of running a brief psychoeducation group intervention in an outpatient setting to assess the practicalities and benefits of offering this type of intervention for both clinicians and patients
Detailed description
A Functional Neurological Disorder (FND) is when the brain has difficulties sending and receiving signals . As a result people can experience problems in how their body and senses work, but there is no physical problem to treat. Currently there is little treatment to offer after diagnosis, this study will investigate the feasibility and potential benefit to offering a group intervention to people with FND. This group intervention will offer chance to access information and the opportunity to meet others with the similar difficulties. Eligible participants will be those currently attending neurology clinics within NHS Grampian. Participants will complete prior to, during and at 3 months after the group is completed. These measures include health care use of participants, reported physical symptoms, subjective quality of ife and mood we will also take a brief measure of attention and concentration. Reported physical symptoms, subjective quality of life and mood will also be collected before the first group and at the last group.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Psychoeducation Group for FND | he intervention is a psychoeducation based group. |
Timeline
- Start date
- 2019-05-01
- Primary completion
- 2019-12-01
- Completion
- 2020-09-01
- First posted
- 2019-02-27
- Last updated
- 2019-10-09
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT03857347. Inclusion in this directory is not an endorsement.